Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHVmutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHVmutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI

Published:2017-02-13 Issue:4 Volume:92 Page:375-380
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Delgado Julio¹,Doubek Michael²³,Baumann Tycho¹,Kotaskova Jana²³,Molica Stefano⁴,Mozas Pablo¹,Rivas-Delgado Alfredo¹,Morabito Fortunato⁵,Pospisilova Sarka²³,Montserrat Emili¹^ORCID

Affiliation:

1. Department of Hematology; Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona; Barcelona Spain

2. Department of Internal Medicine - Hematology and Oncology; University Hospital Brno and Medical Faculty; Brno Czech Republic

3. Central European Institute of Technology (CEITEC), Masaryk University; Brno Czech Republic

4. Department Hematology-Oncology; Azienda Ospedaliera Pugliese-Ciaccio; Catanzaro Italy

5. UOC Ematologia, Azienda Ospedaliera di Cosenza; Cosenza Italy

Funder

Red Temática de Investigación Cooperativa en Cancer RT

Instituto de Salud Carlos III

ICGC-CLL Genome Project, Generalitat de Catalunya

“Emili Letang” (T.B.); Ministry of Health of the Czech Republic (The Czech team)

Ministry of Education, Youth and Sports of the Czech Republic project NPUII - CEITEC 2020

Publisher

Wiley

Subject

Hematology

Reference49 articles.

1. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines;Hallek;Blood.,2008

2. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia;Ghia;Leukemia.,2007

3. Survival analysis in hematologic malignancies: Recommendations for clinicians;Delgado;Haematologica.,2014

4. The molecular pathogenesis of chronic lymphocytic leukaemia;Fabbri;Nat Rev Cancer.,2016

5. Clinical staging of chronic lymphocytic leukemia;Rai;Blood.,1975

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia;Farmacia Hospitalaria;2024-01

2. Comparación indirecta ajustada de zanubrutinib e ibrutinib en el tratamiento de primera línea de la leucemia linfocítica crónica;Farmacia Hospitalaria;2024-01

3. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany;Clinical and Experimental Medicine;2023-11-18

4. The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When;Cancers;2023-09-02

5. Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon;Future Oncology;2023-09